The relationships among host immune and viral factors and the severity of liver disease due to hepatitis C virus (HCV) are poorly understood. Previous studies have focused on individual components of the immune response to HCV, often in relatively small numbers of patients. We measured HCV-specific
Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C
✍ Scribed by González-Peralta, Regino P.; Qian, Keping; She, Jan Y.; Davis, Gary L.; Ohno, Tomoyoshi; Mizokami, Masashi; Lau, Johnson Y.N.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 648 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
To determine the clinical significance of viral quasispecies heterogeneity, 59 patients with chronic hepatitis C were studied using singlestranded conformational polymorphism (SSCP) analysis of the HCV E2 hypervariable region 1 (HVRI); of these, 48 were subsequently treated with interferon-a. The SSCP method was validated using clones of known nucleotide sequence. HVRI was amplified i n 54 of 59 (92%) patients. The median number of SSCP bands per sample was 6 (range: 2-12). Increased quasispecies heterogeneity correlated with the estimated duration of HCV infection ( P < 0.05), parenteralacquired HCV infection (vs. sporadic, P < 0.05), serum HCV RNA levels ( P < 0.05), and HCV geno-
Methods
Three technical requirements for the development of a SSCP assay were anticipated. First, to assure sensitivity and avoid quasispecies selection bias, PCR primers designed from relatively well-conserved regions of the HCV E2 gene were used. However, to allow for assessment of heterogeneity, the primers flanked a hypervariable region (HVR1) [Kato et al., 19921. Second, the 'nested' amplicons were around 200 bp long, the optimum size for SSCP since it allows easy discrimination of bands after gel separation [Hayashi, 19921. Third, a predetermined quantity of cDNA was gel-loaded for SSCP analysis. This is of particular importance since patients with high level HCV viremia would have more amplicon per 0 1996 WILEY-LISS, INC.
📜 SIMILAR VOLUMES
To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by
## Abstract The purpose of the present study was to assess the viral diversity of hepatitis C virus (HCV) in six nonresponder patients during three unsuccessful treatments. These patients were treated successively with IFN‐α2a (IFN‐α) at a posology of 3.10^6^ units (MIU) three times a week, 10 MIU
The quasispecies nature of hepatitis C virus (HCV) in patients with mixed HCV subtype infection was compared with that in patients with single HCV subtype infection. The number of HCV quasispecies was compared between 35 patients with mixed HCV subtype infection and 83 patients with single subtype i
Hepatitis C virus (HCV) carriers usually have antibodies to HCV; however, there are viremic individuals without these antibodies. To investigate whether variations of the viral genome are responsible for this discrepancy, the nucleotide and deduced amino acid sequences of HCV capsid and nonstructura
## Abstract The prevalence of antibodies to hepatitis C virus (anti‐HCV) was determined in 105 patients with biopsy‐proven chronic liver disease and 128 comparison patients without any evidence of liver pathology living in Lima, Peru. Using a second‐generation EIA screening and supplemental immunob